Casey Woodring
Stock Analyst at JP Morgan
(0.40)
# 4,046
Out of 4,876 analysts
33
Total ratings
20%
Success rate
-20.55%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $144.56 | +3.76% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $28.87 | -13.40% | 4 | Apr 21, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $150.01 | +9.99% | 7 | Feb 20, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $65.01 | +44.59% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $47.77 | +16.43% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.01 | +99.34% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $18.59 | +23.72% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $11.32 | +59.01% | 2 | Jan 23, 2023 |
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $144.56
Upside: +3.76%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $28.87
Upside: -13.40%
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $150.01
Upside: +9.99%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $65.01
Upside: +44.59%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $47.77
Upside: +16.43%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.01
Upside: +99.34%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $18.59
Upside: +23.72%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $11.32
Upside: +59.01%